骨成長刺激剤市場：製品、用途、流通チャネル別-2025-2030年の世界予測

骨成長刺激剤市場は、2023年に25億米ドルと評価され、2024年には26億8,000万米ドルに達すると予測され、CAGR 7.54％で成長し、2030年には41億6,000万米ドルになると予測されています。

骨成長刺激剤は、骨折や脊椎固定術の治癒プロセスを促進するために使用される医療機器です。治癒が遅れたり、損なわれたりする可能性のある骨形成を促進する上で重要な役割を果たします。主に整形外科、外科、歯科において、癒合していない骨折、脊椎固定、その他の骨関連疾患の治療に使用されます。主な用途は骨再生を必要とする治療法にも及び、外傷や傷害の回復に不可欠なものとなっています。最近の進歩により、これらの器具の最終使用範囲は、病院、外来手術センター、整形外科専門クリニックにまで拡大しています。

骨成長刺激剤市場は、骨関連疾患の罹患率の増加、非侵襲的治療に対する需要の増大、変性骨疾患に罹患しやすい世界の高齢化人口の増加によって大きく牽引されています。超音波やパルス電磁場技術などの技術進歩が市場拡大をさらに後押しします。ヘルスケア支出の増加と意識の高まりが、さらに勢いを増す要因となっています。しかし、市場は高コストと厳しい規制の枠組みが機器の承認とその後の商業化を妨げるという課題に直面しています。

新たなビジネスチャンスは、個別化骨成長刺激剤の開発と、患者のコンプライアンスと治療成果を高めるためのIoTの統合にあります。これは、リハビリテーション医療におけるより革新的なアプリケーションや、技術的進歩のための合併やコラボレーションの可能性につながる可能性があります。企業にとっては、研究開発に投資して費用対効果の高いポータブル機器を開発することで、サービスが行き届いていない地域市場を開拓し、消費者基盤を拡大できる可能性があります。とはいえ、従来の疼痛管理ソリューションとの競合や、こうした機器の有効性に関する懐疑的な見方が、継続的な障害となっています。

市場の成長を維持するためには、治療の精度と最小限の侵襲性に重点を置くとともに、有利なヘルスケア政策への働きかけが不可欠となります。未開発の市場を開拓し、ビッグデータ解析を活用して患者の転帰を予測・改善することは、技術革新の有望な道筋を示すものです。エビデンスに基づく患者中心のアプローチへの移行が進む中、この市場のダイナミックな性質を理解することは不可欠です。

市場力学：急速に進化する骨成長刺激剤市場の主要市場インサイトを公開

骨成長刺激剤市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 老人人口の増加と慢性疾患および関節炎の発生率
  • 骨折や事故の増加
  • 低侵襲・非侵襲の外科治療に対する患者の志向の高まり
• 市場抑制要因
  • バッテリー寿命の制限とショートの可能性
• 市場機会
  • 多血小板血漿と骨形成タンパク質の出現
  • 費用対効果の高い骨成長刺激装置の入手可能性
• 市場の課題
  • 感染の可能性と、埋め込んだ器具を除去するための再手術の必要性

ポーターの5つの力：骨成長刺激剤市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：骨成長刺激剤市場における外部からの影響の把握

外部マクロ環境要因は、骨成長刺激剤市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析骨成長刺激剤市場における競合情勢の把握

骨成長刺激剤市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス骨成長刺激剤市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、骨成長刺激剤市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨骨成長刺激剤市場における成功への道筋を描く

骨成長刺激剤市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 高齢者人口の増加と慢性疾患および関節炎の発症率
    • 骨折や事故の発生増加
    • 低侵襲性および非侵襲性の外科治療に対する患者の傾向が高まっている
  • 抑制要因
    • バッテリー寿命が限られており、ショートの可能性がある
  • 機会
    • 多血小板血漿と骨形成タンパク質の出現
    • 費用対効果の高い骨成長刺激装置の入手可能性
  • 課題
    • 感染の可能性があり、埋め込まれたデバイスを除去するために2回目の手術が必要になる
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 骨成長刺激剤市場：製品別

• 骨成長刺激装置
• 骨形成タンパク質
• 多血小板血漿

第7章 骨成長刺激剤市場：用途別

• 骨癒合遅延骨折および骨癒合不全骨折
• 口腔外科および顎顔面外科
• 脊椎固定手術

第8章 骨成長刺激剤市場：流通チャネル別

• 学術調査機関
• 契約調査機関
• ホームケア
• 病院・クリニック

第9章 南北アメリカの骨成長刺激剤市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の骨成長刺激剤市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの骨成長刺激剤市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Altis Biologics（Pty.）Ltd.
• Arthrex, Inc.
• Bioventus LLC
• Boston Scientific Corporation
• BTT Health GmbH
• DJO, LLC
• Elizur Corporation
• Ember Therapeutics, Inc.
• EMS Physio Ltd.
• Ito Co., Ltd.
• Johnson & Johnson Services, Inc.
• Kinex Medical Company, LLC
• Medtronic PLC
• Orthofix Medical Inc.
• Ossatec Benelux Ltd.
• Regen Lab SA
• RS Medical
• Stimulate Health Inc.
• Stryker Corporation
• Terumo Corporation
• Zimmer Biomet Holdings, Inc.
• ZimVie Inc.

LIST OF FIGURES

• FIGURE 1. BONE GROWTH STIMULATORS MARKET RESEARCH PROCESS
• FIGURE 2. BONE GROWTH STIMULATORS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. BONE GROWTH STIMULATORS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. BONE GROWTH STIMULATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. BONE GROWTH STIMULATORS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. BONE GROWTH STIMULATORS MARKET DYNAMICS
• TABLE 7. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY BONE GROWTH STIMULATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY BONE MORPHOGENETIC PROTEINS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY PLATELET-RICH PLASMA, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY DELAYED UNION & NONUNION BONE FRACTURES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY ORAL & MAXILLOFACIAL SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY SPINAL FUSION SURGERIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL BONE GROWTH STIMULATORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. ARGENTINA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. BRAZIL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 30. CANADA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 31. CANADA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 32. CANADA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. MEXICO BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 39. UNITED STATES BONE GROWTH STIMULATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 43. ASIA-PACIFIC BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. AUSTRALIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. CHINA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. CHINA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CHINA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 50. INDIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. INDIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. INDIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. INDONESIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 58. JAPAN BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. MALAYSIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. PHILIPPINES BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 67. SINGAPORE BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 70. SOUTH KOREA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. TAIWAN BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. THAILAND BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 79. VIETNAM BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 83. EUROPE, MIDDLE EAST & AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 86. DENMARK BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. EGYPT BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. FINLAND BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 95. FRANCE BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 98. GERMANY BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. ISRAEL BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 102. ITALY BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 103. ITALY BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. ITALY BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 107. NETHERLANDS BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. NIGERIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. NORWAY BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 114. POLAND BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. POLAND BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 116. POLAND BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 117. QATAR BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 118. QATAR BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 119. QATAR BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. RUSSIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. SAUDI ARABIA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 128. SOUTH AFRICA BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 131. SPAIN BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. SWEDEN BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. SWITZERLAND BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 140. TURKEY BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 143. UNITED ARAB EMIRATES BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM BONE GROWTH STIMULATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM BONE GROWTH STIMULATORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. UNITED KINGDOM BONE GROWTH STIMULATORS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 147. BONE GROWTH STIMULATORS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 148. BONE GROWTH STIMULATORS MARKET, FPNV POSITIONING MATRIX, 2023

The Bone Growth Stimulators Market was valued at USD 2.50 billion in 2023, expected to reach USD 2.68 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 4.16 billion by 2030.

Bone growth stimulators are medical devices used to enhance the healing process of fractures or spinal fusions. They are key in promoting osteogenesis where healing might otherwise be slow or impaired. They are primarily used in orthopedic, surgical, and dental settings to treat non-union fractures, spinal fusions, and other bone-related conditions. Key applications extend to therapeutic procedures that require bone regeneration, making them imperative in trauma and injury recovery. Recent advancements have expanded the end-use scope of these devices to include hospitals, ambulatory surgical centers, and specialized orthopedic clinics.

The bone growth stimulators market is significantly driven by the increasing incidence of bone-related disorders, augmented demand for non-invasive therapies, and a rise in the global aging population susceptible to degenerative bone diseases. Technological advancements, such as ultrasound and pulsed electromagnetic field technologies, further bolster market expansion. Increasing healthcare expenditure and heightened awareness contribute further momentum. However, the market faces challenges with high costs and the stringent regulatory framework hampering device approval and subsequent commercialization.

Emerging opportunities lie in developing personalized bone growth stimulators and integrating IoT to enhance patient compliance and therapy outcomes. This could lead to more innovative applications in rehabilitation medicine and potential mergers and collaborations for technological advancements. For businesses, investing in R&D to create cost-effective, portable devices could tap into underserved regional markets and expand consumer base. Nonetheless, competition from traditional pain management solutions and skepticism related to the efficacy of these devices pose ongoing roadblocks.

To sustain market growth, focusing on the precision and minimal invasiveness of treatments, while lobbying for favorable healthcare policies, will be crucial. Exploring underdeveloped markets and leveraging big data analytics to predict and improve patient outcomes represent promising avenues for innovation. Understanding this market's dynamic nature is essential as it transitions increasingly toward an evidence-based, patient-centered approach.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Bone Growth Stimulators Market

The Bone Growth Stimulators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rise in geriatric population and incidence of chronic diseases and arthritis
  • Increase in occurrences of fracture and accidents
  • Growing patient inclination toward minimally invasive & non-invasive surgical treatments
• Market Restraints
  • Limited battery life and potential short circuiting
• Market Opportunities
  • Emergence of platelet-rich plasma and bone morphogenetic protein
  • Availability of cost effective bone growth stimulation devices
• Market Challenges
  • Potential for infection and need for a second procedure for removal of the implanted devices

Porter's Five Forces: A Strategic Tool for Navigating the Bone Growth Stimulators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Bone Growth Stimulators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Bone Growth Stimulators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Bone Growth Stimulators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Bone Growth Stimulators Market

A detailed market share analysis in the Bone Growth Stimulators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Bone Growth Stimulators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Bone Growth Stimulators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Bone Growth Stimulators Market

A strategic analysis of the Bone Growth Stimulators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Bone Growth Stimulators Market, highlighting leading vendors and their innovative profiles. These include Altis Biologics (Pty.) Ltd., Arthrex, Inc., Bioventus LLC, Boston Scientific Corporation, BTT Health GmbH, DJO, LLC, Elizur Corporation, Ember Therapeutics, Inc., EMS Physio Ltd., Ito Co., Ltd., Johnson & Johnson Services, Inc., Kinex Medical Company, LLC, Medtronic PLC, Orthofix Medical Inc., Ossatec Benelux Ltd., Regen Lab SA, RS Medical, Stimulate Health Inc., Stryker Corporation, Terumo Corporation, Zimmer Biomet Holdings, Inc., and ZimVie Inc..

Market Segmentation & Coverage

This research report categorizes the Bone Growth Stimulators Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, and Platelet-Rich Plasma.
• Based on Application, market is studied across Delayed Union & Nonunion Bone Fractures, Oral & Maxillofacial Surgeries, and Spinal Fusion Surgeries.
• Based on Distribution Channel, market is studied across Academic & Research Institutes, Contract Research Organizations, Home Care, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rise in geriatric population and incidence of chronic diseases and arthritis
    • 5.1.1.2. Increase in occurrences of fracture and accidents
    • 5.1.1.3. Growing patient inclination toward minimally invasive & non-invasive surgical treatments
  • 5.1.2. Restraints
    • 5.1.2.1. Limited battery life and potential short circuiting
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of platelet-rich plasma and bone morphogenetic protein
    • 5.1.3.2. Availability of cost effective bone growth stimulation devices
  • 5.1.4. Challenges
    • 5.1.4.1. Potential for infection and need for a second procedure for removal of the implanted devices
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Bone Growth Stimulators Market, by Product

• 6.1. Introduction
• 6.2. Bone Growth Stimulation Devices
• 6.3. Bone Morphogenetic Proteins
• 6.4. Platelet-Rich Plasma

7. Bone Growth Stimulators Market, by Application

• 7.1. Introduction
• 7.2. Delayed Union & Nonunion Bone Fractures
• 7.3. Oral & Maxillofacial Surgeries
• 7.4. Spinal Fusion Surgeries

8. Bone Growth Stimulators Market, by Distribution Channel

• 8.1. Introduction
• 8.2. Academic & Research Institutes
• 8.3. Contract Research Organizations
• 8.4. Home Care
• 8.5. Hospitals & Clinics

9. Americas Bone Growth Stimulators Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Bone Growth Stimulators Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Bone Growth Stimulators Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Altis Biologics (Pty.) Ltd.
• 2. Arthrex, Inc.
• 3. Bioventus LLC
• 4. Boston Scientific Corporation
• 5. BTT Health GmbH
• 6. DJO, LLC
• 7. Elizur Corporation
• 8. Ember Therapeutics, Inc.
• 9. EMS Physio Ltd.
• 10. Ito Co., Ltd.
• 11. Johnson & Johnson Services, Inc.
• 12. Kinex Medical Company, LLC
• 13. Medtronic PLC
• 14. Orthofix Medical Inc.
• 15. Ossatec Benelux Ltd.
• 16. Regen Lab SA
• 17. RS Medical
• 18. Stimulate Health Inc.
• 19. Stryker Corporation
• 20. Terumo Corporation
• 21. Zimmer Biomet Holdings, Inc.
• 22. ZimVie Inc.